SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) received a Notice of Allowance from the United States Patent and Trademark Office on a patent application which broadens protection of the Company’s Celution® System. The more than 40 allowed claims create several new layers of protection related to the automated processing of stem and regenerative cells from adipose tissue. Key claims include the following:
